Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H20N4O.C4H6O4 |
Molecular Weight | 510.5405 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CCC(O)=O.CN1C=C(C(=N1)C2=CC=C(OCC3=NC4=CC=CC=C4C=C3)C=C2)C5=CC=NC=C5
InChI
InChIKey=AVSAEIJRBBJXNR-UHFFFAOYSA-N
InChI=1S/C25H20N4O.C4H6O4/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21;5-3(6)1-2-4(7)8/h2-16H,17H2,1H3;1-2H2,(H,5,6)(H,7,8)
Molecular Formula | C4H6O4 |
Molecular Weight | 118.088 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C25H20N4O |
Molecular Weight | 392.4525 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:25:49 UTC 2023
by
admin
on
Fri Dec 15 15:25:49 UTC 2023
|
Record UNII |
TJ5KAZ8T5G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
429914
Created by
admin on Fri Dec 15 15:25:49 UTC 2023 , Edited by admin on Fri Dec 15 15:25:49 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000183836
Created by
admin on Fri Dec 15 15:25:49 UTC 2023 , Edited by admin on Fri Dec 15 15:25:49 UTC 2023
|
PRIMARY | |||
|
1037309-45-7
Created by
admin on Fri Dec 15 15:25:49 UTC 2023 , Edited by admin on Fri Dec 15 15:25:49 UTC 2023
|
PRIMARY | |||
|
TJ5KAZ8T5G
Created by
admin on Fri Dec 15 15:25:49 UTC 2023 , Edited by admin on Fri Dec 15 15:25:49 UTC 2023
|
PRIMARY | |||
|
24857794
Created by
admin on Fri Dec 15 15:25:49 UTC 2023 , Edited by admin on Fri Dec 15 15:25:49 UTC 2023
|
PRIMARY | |||
|
DTXSID90647726
Created by
admin on Fri Dec 15 15:25:49 UTC 2023 , Edited by admin on Fri Dec 15 15:25:49 UTC 2023
|
PRIMARY | |||
|
EU/3/16/1691(POSITIVE)
Created by
admin on Fri Dec 15 15:25:49 UTC 2023 , Edited by admin on Fri Dec 15 15:25:49 UTC 2023
|
PRIMARY | On 14 July 2016, orphan designation (EU/3/16/1691) was granted by the European Commission to Pfizer Limited, United Kingdom, for 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline succinic acid for the treatment of Huntington's disease. |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |